SCHEMBL11704652

SCHEMBL11704652

Cc1cc(N)ccc1OCCO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.47
ALDH1A1 P00352 5/20 0.47
MAPT P10636 4/20 0.47
GAA P10253 3/20 0.47
CASP1 P29466 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
TP53 P04637 2/20 0.47
USP2 O75604 1/20 0.47
POLB P06746 1/20 0.47
HTT P42858 1/20 0.47
CASP7 P55210 1/20 0.47
ATM Q13315 1/20 0.47
PDE10A Q9Y233 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.41
IDO1 P14902 1/20 0.40
TSHR P16473 1/20 0.39
ESR1 P03372 2/20 0.39
ALOX15 P16050 2/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11706792 0.91 ALDH1A1 (0.46) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL20496732 0.88 ALDH1A1 (0.53) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL30694100 0.86 KDM4E (0.52) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL11691609 0.85 TSHR (0.44) KDM4EALDH1A1MAPTGAACASP1
Hydrochloric Acid SCHEMBL18243323 0.84 ALDH1A1 (0.59) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL10187274 0.83 MAPT (0.68) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL2601944 0.82 GAA (0.52) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL10188110 0.81 ALDH1A1 (0.56) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL4658980 0.81 KDM4E (0.47) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL29358757 0.81 MAPT (0.65) KDM4EALDH1A1MAPTGAACASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248837-A1 Technology for Modulating Targeting Chimeras Induced by Cell-Penetrating Peptide and Application Thereof LIU, MIAO (CN) 2023-08-10 US disclosed
US-9682976-B2 Protein kinase C inhibitors and uses thereof RIGEL PHARMACEUTICALS, INC. (US) 2017-06-20 US disclosed
US-9682976-B2 Protein kinase C inhibitors and uses thereof RIGEL PHARMACEUTICALS, INC. (US) 2017-06-20 US disclosed
US-20160257681-A1 Protein Kinase C Inhibitors and Uses Thereof MIDCAP FINANCIAL TRUST 2016-09-08 US disclosed
US-20160257681-A1 Protein Kinase C Inhibitors and Uses Thereof MIDCAP FINANCIAL TRUST 2016-09-08 US disclosed
US-4036824-A Disazo dyestuffs containing A-O-alkylene-O-SO3 H group BAYER AKTIENGESELLSCHAFT (DT) 1977-07-19 US disclosed
US-3956267-A Indole-containing disazo dyestuffs having a sulfatoalkyleneoxy-substituent BAYER AKTIENGESELLSCHAFT (DT) 1976-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160257681-A1 Protein Kinase C Inhibitors and Uses Thereof PRKCH, PRKCA, PRKCB KDM4E 2813/4885ALDH1A1 4361/4885MAPT 2530/4885
US-20230248837-A1 Technology for Modulating Targeting Chimeras Induced by Cell-Penetrating Peptide and Application Thereof VIP, GHITM, MYCBP KDM4E 3694/4885ALDH1A1 4851/4885MAPT 4121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.